Shanghai Yitai Pharmaceutical Technology Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Shanghai Yitai Pharmaceutical Technology General Information
Description
Provider of bio-pharmaceutical services intended to develop and commercialize innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The company's bio-pharmaceutical services include developing synthetic peptide analog of human parathyroid hormone-related protein (hPTHrP) which is a bone-building hormone and product for the treatment of osteoporosis in both injection and transdermal methods of administration, enabling doctors to cure their patients quickly.
Contact Information
Website
www.re188.com(Operating Subsidiary)
Corporate Office
- Flour B Block 3 Floors,Lane 879
- Zhongjiang Road
- Shanghai, 200062
- China
Corporate Office
- Flour B Block 3 Floors,Lane 879
- Zhongjiang Road
- Shanghai, 200062
- China
Shanghai Yitai Pharmaceutical Technology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shanghai Yitai Pharmaceutical Technology Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shanghai Yitai Pharmaceutical Technology FAQs
-
When was Shanghai Yitai Pharmaceutical Technology founded?
Shanghai Yitai Pharmaceutical Technology was founded in 2016.
-
Where is Shanghai Yitai Pharmaceutical Technology headquartered?
Shanghai Yitai Pharmaceutical Technology is headquartered in Shanghai, China.
-
What industry is Shanghai Yitai Pharmaceutical Technology in?
Shanghai Yitai Pharmaceutical Technology’s primary industry is Drug Discovery.
-
Is Shanghai Yitai Pharmaceutical Technology a private or public company?
Shanghai Yitai Pharmaceutical Technology is a Private company.
-
What is the current valuation of Shanghai Yitai Pharmaceutical Technology?
The current valuation of Shanghai Yitai Pharmaceutical Technology is .
-
What is Shanghai Yitai Pharmaceutical Technology’s current revenue?
The current revenue for Shanghai Yitai Pharmaceutical Technology is .
-
Who are Shanghai Yitai Pharmaceutical Technology’s investors?
Zhejiang Xingpeng Copper Material has invested in Shanghai Yitai Pharmaceutical Technology.
-
When was Shanghai Yitai Pharmaceutical Technology acquired?
Shanghai Yitai Pharmaceutical Technology was acquired on 18-Oct-2016.
-
Who acquired Shanghai Yitai Pharmaceutical Technology?
Shanghai Yitai Pharmaceutical Technology was acquired by Yantai Dongcheng Pharmaceutical Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process